| Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call (Business Wire) CAMBRIDGE, Mass.----Ironwood Pharmaceuticals, Inc. today announced it will participate in the J.P. Morgan Biotech: CEO/CFO Conference Call Series at 10:00 a.m. Eastern Time on Friday, May 28, 2010. us.rd.yahoo.com |
PPD names Wilkinson chief information officer (AP) Contract research organization Pharmaceutical Product Development Inc. on Tuesday promoted Michael Wilkinson to the newly created position of chief information officer. us.rd.yahoo.com |
Fresh Express Launches Artisanal Salads - Video Salads offer Seasonal Taste in Innovative Natursave™ Packaging feedproxy.google.com |
Bristol to Buy ZymoGenetics Bristol-Myers Squibb agreed to acquire biotechnology company ZymoGenetics Inc. for $9.75 a share in cash, in a deal valued at about $885 million. online.wsj.com |
Sanofi-Aventis Enters Collaboration With Harvard in Effort to Externalize R&D The Burrill Report submits: By Daniel S. Levine Sanofi-Aventis (SNY) has entered into a research collaboration with Harvard University in the hopes of accelerating discoveries from the lab to the clinic. The translational research collaboration extends across several therapeutic areas including cancer, diabetes and inflammation. Under the collaboration, Harvard University investigators will propose research projects across a wide range of areas. The funded projects will be selected by a Joint Scientific Steering Committee comprised of representatives of Sanofi-Aventis and Harvard. Projects will be awarded funding based on their scientific merit and potential to generate translational insight and value to biomedical research. The collaboration provides Sanofi-Aventis the opportunity to develop diagnostic, therapeutic and prognostic applications of discoveries made. Complete Story » seekingalpha.com |